Abstract
for the RCE
Bacillus
anthracis Host
Interactions
Discovery
of Subunit Vaccine Candidates against
Glanders
Alphavirus
Vaccines for Biodefense
Novel
Genetic Tools for Viral Biodefense
Development
and Evaluation of Human
Brucellosis
Vaccines
Rapid
Diagnostic Tools for Q Fever
New
Diagnostic Methods for Accute Rickettsial
Infections
Risks
and Interventions for Pandemic Influenza
Development
of Novel Pseudoinfectious Flavivirus Vaccines
Development
of Diagnostic Reagents for the detection
of
Francisella and
Francisella
Infection
Toward
Control of Rift Valley Fever Virus
Replication
Novel
Vaccine Technology for Biodefense
Nucleocapsid-specific
Small Molecule Inhibitors
of
the Bunyaviridae
New
Technologies for Creating Affinity Reagents
New Opportunities Projects
Identification
and Characterization of Novel
Flavivirus
Antivirals
Biosafety
Containment Training Program
Passive
Immunotherapeutics for
Select
Agents
Preclinical
Testing of YF17D/LAS, a Bivalent
Vaccine
for Lassa and
Yellow
Fever
|
Nucleocapsid-specific
Small Molecule Inhibitors of the Bunyaviridae
Collaborating
Institution: Univeristy of New Mexico, Albuquerque, NM
Principal
Investigator: Antonito Panganiban, PhD
Co-Investigators: M. Ayoub Mir, PhD - University of New Mexico, Albuquerque, NM
Expected
Product: Identify compounds to be developed into new antiviral
agents for bunyaviruses.
Description: The Bunyaviridae family
of viruses includes a set of Category A and C virus species.
For the Bunyaviridae these include the
members of the Hantavirus genus, as well as Rift Valley fever
virus and Crimean-Congo hemorrhagic fever virus. Current therapies
against most of these viruses either do not exist or are only
marginally efficient. Thus, it would be highly beneficial to
identify and develop additional drugs directed at specific viral
targets required for replication. The goal of this revised proposal
is to refine and use an assay system for the identification of
molecules that disrupt the function of the principle nucleocapsid
protein of these viruses, and to carry out screening for such
candidate drugs. The nucleocapsid protein (N) functions both
in the process of RNA encapsidation during virus assembly and
during genome replication in conjunction with the viral polymerase.
Since these are essential steps in virus replication, disruption
of one or both processes would effectively block virus propagation.
Our basic work indicates that for the Bunyaviridae, the principle
in vitro RNA substrate for N is the RNA panhandle formed by the
hydrogen bonding of the genome termini. In vivo discrimination
and encapsidation of minus strand viral RNAs likely requires
high affinity interaction of N with the panhandle. Our approach
will be to use this specific interaction as the basis of a rapid
and convenient assay to identify molecules that block N function.
This is likely to lead to the identification of a constellation
of novel candidate molecules that interfere with the correct
interaction of N with vRNA. Candidate molecules will be examined
for their effect on cell viability and virus replication.
|